2/18/2022 | BKCVDDEMIGPV | Market Commentary: Junk secondary lower as investors flee risk ahead of long weekend; CSC down; Mednax active
|
2/3/2022 | BKCVDDEMIGPV | Market Commentary: Four junk issuers sell $4 billion; real money accounts sell in secondary; outflows top $4 billion
|
2/2/2022 | BKCVDDEMIGPV | Market Commentary: AMC, Mednax, Boyne sell new junk; volatility returns; Bausch gains; cruise lines improve
|
3/31/2020 | BKHYIG | S&P cuts Mednax to BB-
|
2/24/2020 | BKHYIG | S&P revises Mednax view to negative
|
2/21/2020 | BKHYIG | Moody’s reviews Mednax for trim
|
11/11/2019 | BKHYIG | Moody’s revises Mednax view to negative
|
10/28/2019 | BKHYIG | S&P trims Mednax
|
5/20/2019 | BKBWHYIG | Mednax expects ‘meaningful’ cash flow this year, will pay down debt
|
2/20/2019 | BKCVDDEMIGPV | Market Commentary: Springleaf, Antero Midstream price; XPO in focus; Mednax trades up; Uniti down
|
2/19/2019 | BKCVDDEMIGPV | Market Commentary: XPO prices new offering, existing bonds decline; Mednax prices add-on; Windstream tanks
|
2/19/2019 | IG | Market Commentary: Daimler, American Express, Westpac, Caterpillar, Ventas, Huntington price; busy primary eyed
|
2/19/2019 | HYIG | New Issue: Mednax sells upsized $500 million tap of 6¼% notes due 2027 at 99.75
|
2/19/2019 | IG | Market Commentary: Morning Commentary: American Express, Westpac, Caterpillar on tap; Weyerhaeuser active
|
2/19/2019 | HYIG | Mednax to price $200 million tap of 6¼% notes due 2027 in drive-by crossover deal
|
11/7/2018 | BKCVDDEMIGPV | Market Commentary: Mednax prices; HC2, LifePoint on tap; Dean Foods, Coty under pressure post-earnings
|
11/7/2018 | IG | Market Commentary: MPLX, CSX, Paccar Financial tap primary market; Volkswagen in high-grade deal pipeline
|
11/7/2018 | HYIG | New Issue: Mednax sells downsized $500 million split-rated 8.2-year notes at par to yield 6¼%
|
11/7/2018 | BKHYIG | S&P rates Mednax notes BBB-
|
11/6/2018 | BKIG | S&P revises Mednax view to negative
|
6/13/2016 | BKIG | Moody’s: Mednax unaffected on acquisition
|
12/3/2015 | BKCVDDEMIGPV | Market Commentary: HCA, Aramark, Group 1 price deals; new bonds busy; Chesapeake off; funds gain $398 million
|
12/3/2015 | HYIG | New Issue Mednax sells upsized $750 million split-rated eight-year notes at par to yield 5¼%
|
12/3/2015 | HYIG | Mednax talks $500 million split-rated eight-year notes at 5¼%-5½%; pricing Thursday
|
12/2/2015 | BKCVDDEMIGPV | Market Commentary: Ball brings three-part deal; new Ball bonds gain; Synovus, Churchill Downs also price
|
11/30/2015 | BKCVDDEMIGPV | Market Commentary: Market ends November quietly with no pricings; NGL, Mednax, Ball Corp., shopping deals
|
11/30/2015 | HYIG | Mednax sets roadshow for $500 million offering of eight-year notes
|